La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Outset Medical a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Outset Medical..

Outset Medical (NASDAQ:OM) Azioni, Catena delle Opzioni

Outset Medical

Outset Medical Inc is a medical technology company. It has developed a machine, Tablo, which reduces the cost and complexity of dialysis. Tablo provides Renal Replacement Therapy in Hospitals, Chronic Care in Dialysis Clinics and Home Dialysis.

Earnings

News

Pre-Market Outlook

Markets

Trading Ideas

BLBD

USFD

Scopri i 5 titoli da seguire oggi, 8 agosto 2024: Eli Lilly, Blue Bird e altri protagonisti dei mercati finanziari.

Pre-market: 5 titoli da monitorare oggi, 8 agosto 2024

Outset Medical Inc

MANTRA DAO

IS TRB 3-7 UCITS ETF

Grupo Aeroportuario del Centro Norte S.A.B. de C.V. - American Depositary Shares each representing 8 Series B shares

Grupo Aeroportuario del Centro Norte SAB de CV

Omagine Inc

Origin Protocol - United States Dollar

Omnicom Group Inc

Old Market Capital Corporation - Common Stock

Old Market Capital Corp

Omnicell Inc

ORMAND INDUSTRIES INC by Ormand Industries, Inc.

Ormand Inds Inc

OptMed, Inc.

Omeros Corp

Odyssey Marine Exploration, Inc. - Common Stock

Odyssey Marine Exploration Inc

OneMain Holdings Inc

Invesco Exchange-Traded Self-Indexed Fund Trust Invesco Russell 1000 Dynamic Multifactor ETF

Invesco Exchange-Traded Self-Indexed Fund Trust Invesco Russell 2000 Dynamic Multifactor ETF

ONEMAIN HOLDINGS ORD

OmiseGO - United States Dollar

Omega Therapeutics Inc

OMAI GOLD MINES CORP by OMAI GOLD MINES CORP.

Omai Gold Mines Corp

OMEGA PAC RES INC by Omega Pacific Resources Inc.

Omega Pacific Resources Inc

Ohmyhome Ltd

Omni Health Inc

OM HOLDINGS INTL INC by OM Holdings International, Inc.

Om Holdings International Inc

OM Holdings Ltd

Owens & Minor Inc

Singular Genomics Systems, Inc. - Common Stock

Singular Genomics Systems Inc

Omid Holdings Inc

oOh media Ltd

OMNIMMUNE HOLDINGS INC by Omnimmune Holdings, Inc.

Omnimmune Holdings Inc

OMINECA MINING & MTLS ORD by Omineca Mining & Metals Ltd.

Omineca Mining and Metals Ltd

Omni Network - United States Dollar

Omphalos Corp

OMNIQ Corp

OMRON Corp

Orthometrix Inc

OMS Energy Technologies Inc

OMNITEK ENGINEERING CORP by Omnitek Engineering Corp.

OmniTek Engineering Corp

Omni Ventures Inc

OMV AG

Omnia Wellness Inc

Osisko Metals Inc

With U.S. stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects CVS Health Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) to report quarterly earnings at $1.53 per share on revenue of $92.75 billion before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. CVS Health shares rose 0.7% to $55.70 in after-hours trading.</li>
<li>Globus Medical, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GMED#NYSE">GMED</a>) reported better-than-expected third-quarter financial results and issued FY24 guidance above estimates. The company reported quarterly earnings of 83 cents per share which beat the analyst consensus estimate of 65 cents per share. The company reported quarterly sales of $625.71 million which beat the analyst consensus estimate of $603.93 million. Globus Medical shares surged 10.3% to $83.35 in the after-hours trading session.</li>
<li>Analysts are expecting Johnson Controls International plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JCI#NYSE">JCI</a>) to post quarterly earnings at $1.2 per share on revenue of $7.17 billion. The company will release earnings before the markets open. Johnson Controls International shares rose 2.3% to $76.55 in after-hours trading.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>Super Micro Computer, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) lowered its financial outlook. The company expects to report first-quarter revenue of $5.9 billion to $6 billion, down from its previous guidance range of $6 billion to $7 billion. The company anticipates adjusted earnings of 75 cents to 76 cents per share, versus its previous guidance of 67 cents to 83 cents per share. Super Micro Computer shares dipped 16% to $23.28 in the after-hours trading session.</li>
<li>Analysts expect Qualcomm Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) to report quarterly earnings at $2.56 per share on revenue of $9.9 billion after the closing bell. QUALCOMM shares gained 0.2% to $166.19 in after-hours trading.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/41744659/jim-cramer-says-he-cant-recommend-this-major-automaker-ceva-is-way-too-high">Jim Cramer Says He Can&#8217;t Recommend This Major Automaker, Ceva Is &#8216;Way Too High&#8217;</a></li>
</ul>
Photo courtesy: Shutterstock

Equities

GMED

QCOM

SMCI

CVS Health, Johnson Controls And 3 Stocks To Watch Heading Into Wednesday

Benzinga Election Update: AP Projects Trump With 267 Electoral Votes, Harris With 214 Electoral Votes, AP Calls Trump Win In Pennsylvania

<a href="https://www.youtube.com/watch?v=7Vn6dYEX2_s  " title="https://www.youtube.com/watch?v=7Vn6dYEX2_s  ">https://www.youtube.com/watch?v=7Vn6dYEX2_s&nbsp;&nbsp;</a>

Macro Economic Events

Politics

Econ #s

Economics

General

47th President Donald. J. Trump Speaks At Campaign Watch Party In Florida

EV startup Canoo Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOEV#NASDAQ">GOEV</a>) appointed Kunal Bhalla as its Chief Financial Officer on Oct. 31, following the resignation of Greg Ethridge.
What Happened: Bhalla has been with Canoo since late 2020 and served in multiple roles. Before Canoo, he was an investment banker with Rothschild and Co. as a Director of M&amp;A focused on the Mobility Technology sector.
Ethridge&#8217;s resignation was not the sole one recently at Canoo. Hector Ruiz, General Counsel and Corporate Secretary of Canoo, also resigned from the startup on Oct. 31. The company subsequently chose Sean Yan as&nbsp;General Counsel.
Canoo also said that it will temporarily reduce its workforce in Oklahoma City by furloughing 23% of its factory workers for a period of twelve weeks.&nbsp;
Why It Matters: Canoo in September <a href="https://www.benzinga.com/news/24/08/40570834/ev-startup-canoo-follows-teslas-footsteps-to-move-headquarters-from-california-to-texas">named Justin, Texas</a> as its new company headquarters. The company then said that about 137 engineering positions will relocate from California to Texas and Oklahoma beginning in the fourth quarter of 2024 as part of the headquarters relocation.
Canoo&#8217;s finances have recently been under duress. For the <a href="https://www.benzinga.com/news/earnings/24/08/40380998/canoo-reports-q2-results-reduced-expenses-lower-cash-outflow">three months ending June</a>, Canoo reported a revenue of $605,000 and adjusted net loss per share of $0.61. The company had cash, cash equivalents, and restricted cash of just $19.1 million as of Jun. 30.
Check out more of Benzinga's Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/11/41738613/elon-musk-rejects-rumors-of-a-tesla-phone-but-says-the-ev-giant-will-have-to-make-one-if-this-happen" target="_blank" rel="noreferrer noopener">Elon Musk Rejects Rumors Of A Tesla Phone, But Says The EV Giant Will Have To Make One If This Happens</a></li>
</ul>
Photo courtesy: Canoo

Tech

GOEV

EV Startup Canoo To Furlough 23% Factory Workers In Oklahoma City, CFO Departs

AVPT

Reported Earlier, AvePoint Unveils AI Lab In Singapore To Advance AI And Machine Learning In Data Management

Reported Earlier, HUTCHMED To Present Long-Term Data On Sovleplenib For Chronic ITP At 2024 ASH And ESMO Asia Congress

In connection with the private placement, the Company is planning to issue an aggregate of 2,137,850 units. Each unit will be sold at an effective unit price of $4.28 per unit and will consist of one share of common stock (or one pre-funded warrant in lieu thereof), two (2) Series A warrants, each exercisable for one share of common stock at an initial exercise price of $4.03 per share and one Series B warrant at an exercise price of $0.0001 to purchase such number of shares of common stock as will be determined on the Reset Date (as defined in the Series B warrant).&nbsp;
The closing of the private placement is expected to occur on or about November 6, 2024, subject to the satisfaction of certain customary closing conditions.

ZCAR

Zoomcar Prices $9.15M Private Placement To Advance Debt Repayment And Corporate Growth

As the U.S. presidential election hits a climax with former President Donald Trump taking the lead over Kamala Harris, these five key movements are happening across Wall Street.
Trump Media &amp; Technology Group Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>): The shares of Trump&#8217;s media company have experienced a significant surge fueled by both the anticipation of the election results and the company&#8217;s third-quarter financial results. Data from Nasdaq revealed that the after-hours trading volume for the stock was at 21.9 million, with the stock trading 10.43% higher at $37.48 on Tuesday during after-market hours.
Stock Futures: The stock futures also experienced a rise on election night. Futures associated with the Dow Jones Industrial Average increased by 739 points, or 1.74%, as of 2 a.m. ET. Futures linked to the S&amp;P 500 were up by 1.42%.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>): The anticipation of Trump&#8217;s return to White also boosted Bitcoin to surpass the 75,000 mark and reached 75,249.06 at the time of writing on Wednesday early morning.
See Also: <a href="https://www.benzinga.com/markets/equities/24/11/41703265/haley-tells-pennsylvania-voters-to-put-emotion-aside-and-rally-behind-trump?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Haley Tells Pennsylvania Voters To Put Emotion Aside And Rally Behind Trump</a>
Treasury Yields: Treasury yields also<a href="https://www.benzinga.com/news/24/11/41765345/treasury-yields-pop-on-trump-victory-chances-10-year-benchmark-reaches-4-month-high"> saw an increase in overnight trading </a>as investors evaluated the early results from the tight presidential race. The 10-year Treasury yield jumped 14 basis points to 4.431%, hitting its highest level since July 2. The yield on the 2-year Treasury was up by 8 basis points to 4.285%, reaching its highest level since July 31.
Dollar: The Bloomberg Dollar Spot Index rose sharply by 1.4%, marking its highest point in over three months. The U.S. dollar strengthened across the board against all G10 currencies, with notable increases of over 1% against both the euro and the yen.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/11/41710411/market-analyst-who-predicted-trumps-2016-win-and-bidens-2020-victory-now-sees-former-president-retak?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Market Analyst Who Predicted Trump&#8217;s 2016 Win And Biden&#8217;s 2020 Victory, Now Sees Former President Retakin</a></li>
</ul>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Image via Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

5 Things Moving As Trump Trade Fever Sweeps Wall Street Amid Election Night Drama

AudioCodes (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUDC#NASDAQ">AUDC</a>) reported quarterly earnings of $0.16 per share which missed the analyst consensus estimate of $0.23 by 30.43 percent. This is a 36 percent decrease over earnings of $0.25 per share from the same period last year. The company reported quarterly sales of $60.243 million which missed the analyst consensus estimate of $61.192 million by 1.55 percent. This is a 2.19 percent decrease over sales of $61.591 million the same period last year.

Earnings Misses

AUDC

AudioCodes Q3 2024 Adj. EPS $0.16 Misses $0.23 Estimate, Sales $60.243M Miss $61.192M Estimate

Sales growth is now expected to be 23% to 27% at CER.&nbsp;
Given the current exchange rates versus the Danish krone, sales growth reported in DKK is still expected to be 1 percentage point lower than at CER. The guidance reflects expectations for sales growth in both North America Operations and International Operations, mainly driven by volume growth of GLP-1-based treatments for Obesity and Diabetes care. Continued pricing pressure within Diabetes and Obesity care is included in the guidance.&nbsp;
Following higher-than-expected volume growth in recent years, including GLP-1-based products such as Ozempic&#xAE; and Wegovy&#xAE; , combined with the expectation of continued volume growth and capacity limitations at some manufacturing sites, the outlook also reflects expected continued periodic supply constraints and related drug shortage notifications across a number of products and geographies. Novo Nordisk is investing in internal and external capacity to increase supply both short and long-term.
Operating profit growth is now expected to be 21% to 27% at CER. Given the current exchange rates versus the Danish krone, growth reported in DKK is now expected to be 2 percentage points lower than at CER.
The expectation for operating profit growth primarily reflects the sales growth outlook and continued investments in future and current growth drivers within Research, Development and Commercial. Within R&amp;D, investments are related to the continued expansion and progression of the early and late-stage pipeline. Commercial investments are mainly related to Obesity care market development activities as well as investments related to GLP-1 diabetes care.&nbsp;
Novo Nordisk now expects financial items (net) to amount to a loss of around DKK 0.1 billion. The effective tax rate for 2024 is now expected to be in the range of 20-21%.&nbsp;
Capital expenditure is still expected to be around DKK 45 billion in 2024, reflecting expansion of the global supply chain. The investments will create additional capacity across the supply chain, including manufacturing of active pharmaceutical ingredients (API), additional aseptic production and finished production processes as well as packaging capacity. In the coming years, the capital expenditure to sales ratio is still expected to be low double-digit.&nbsp;
Depreciation, amortisation and impairment losses are still expected to be around DKK 17 billion, including the impairment of ocedurenone.

Guidance

Novo Nordisk 2024 Outlook, Updated: Now Expects Sales Growth Of 23%-27% (Prior 22%-28%) And Operating Profit Growth Of 21%-27% (Prior 20%-28%)

Germany Factory Orders (MoM) For September 4.2% Vs. 1.6% Est.; -5.8% Prior

Approval based on Phase 3 data showing significantly more children aged 1 to 11 years on Dupixent achieved histological disease remission at 16 weeks compared to placebo, which was sustained up to one year
Dupixent is the first-ever medicine in the EU indicated to treat these young patients, who persistently struggle to eat at a critical stage in life where growth is crucial

Health Care

REGN

Regeneron And Sanofi's Dupixent Receives EU Approval For Children With Eosinophilic Esophagitis, Offering New Hope For Ages 1 To 11

Novo Nordisk (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) reported quarterly earnings of DKK6.12 per share which beat the analyst consensus estimate of DKK6.02 by 1.66 percent. This is a 22.4 percent increase over earnings of DKK5.00 per share from the same period last year. The company reported quarterly sales of DKK71.311 billion which missed the analyst consensus estimate of DKK71.891 billion by 0.81 percent. This is a 21.42 percent increase over sales of DKK58.731 billion the same period last year.

Earnings Beats

Novo Nordisk Q3 2024 GAAP EPS DKK6.12 Beats DKK6.02 Estimate, Sales DKK71.311B Miss DKK71.891B Estimate

South Dakota voters rejected Measure 29 on Tuesday, which sought to legalize cannabis for adults. The initiative aimed to allow individuals aged 21 and older to possess limited amounts of cannabis and cultivate plants at home, but it did not receive the necessary <a href="https://www.benzinga.com/cannabis">support from voters.</a>
The Associated Press <a href="https://apnews.com/projects/election-results-2024/south-dakota/?r=83042">reported</a> that with 50% of the votes counted at 2:00 am on Wednesday, the No vote had garnered nearly 60% of the vote. 
Measure 29 proposed that adults could possess up to 2 ounces of cannabis flower, 16 grams of cannabis concentrates, and 1,600 milligrams of THC in other products. It also included provisions for growing up to six cannabis plants at home, with a total limit of 12 plants per residence.
See Also: <a href="https://www.benzinga.com/markets/cannabis/24/06/39364741/majority-of-south-dakotans-are-against-recreational-cannabis-legalization-new-poll-finds">Majority Of South Dakotans Are Against Recreational Cannabis Legalization, New Poll Finds</a>
<h3 class="wp-block-heading">Industry Leaders React: Economic And Social Impacts Of Measure 29&#8217;s Failure</h3>
Gurpreet (Pete) Sahani, CEO of The Blinc Group, expressed disappointment: "The failure of this amendment highlights ongoing challenges in legalizing cannabis in South Dakota. However, the need for reform won't be silenced by this outcome. The push for cannabis legalization will continue."
John Mueller, CEO and co-founder of Greenlight, calls the outcome "a missed opportunity." 
"South Dakota will continue to miss out on the economic and public safety benefits that come with a regulated adult-use cannabis market," he said, stressing that legal access to cannabis provides safer options for consumers.
For Ray DeSabato, CEO of Chorus, the result came as no surprise. "Given South Dakota's traditionally restrictive nature to marijuana, it's unsurprising that this measure failed." He also noted that cultivation quality and compliance are ongoing concerns in cannabis, with current prevention solutions having limited impact.
Peter Dikun, owner of Flower Shop Dispensary, sees the vote as a "huge loss" for both the industry and residents. 
"If IM29 doesn't pass, the state misses out on tax revenue and jobs, and we keep wasting taxpayer dollars on prosecutions," he says. Dikun is also concerned about the growing opposition and spread of misinformation surrounding cannabis.
Todd Smith, CEO of The Hills LLC, predicts: &#8220;A lot of cannabis companies will close their doors. There will only be a handful that stay open and hopefully survive till the next opportunity to get on the ballot.&#8221;
<h3 class="wp-block-heading">Previous Attempts At Legalization</h3>
This was the third attempt at legalizing cannabis in South Dakota. In 2020, Amendment A was passed by 54% of voters but was later overturned by the state Supreme Court. The 2022 initiative, Measure 27, also failed to pass, indicating the challenges faced by cannabis advocates in the state
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/07/39579497/fake-weed-gummies-vape-pens-and-other-hemp-products-banned-in-south-dakota-where-majority-oppose">&#8216;Fake Weed&#8217; Gummies, Vape Pens And Other Hemp Products Banned In South Dakota Where Majority Opposes Recreational Cannabis</a></li>
</ul>
Cover image made with AI.

Cannabis

South Dakota Rejects Measure 29: Cannabis Legalization Fails Again

In a stark contrast of election night atmospheres, former President Donald Trump is rallying his supporters while Vice President Kamala Harris&#8217; campaign has reportedly gone silent, with no plans to address the public.
What Happened: Trump supporters are flocking to the Palm Beach Convention Center to hear the former President speak. Trump is expected to make his way from Mar-a-Lago to address the crowd, <a href="https://apnews.com/live/trump-harris-election-updates-11-5-2024#00000192-fff3-dc56-a39e-fff775770000">reported</a> the Associated Press.
Former presidential candidate Robert F. Kennedy Jr. is the latest to join Trump&#8217;s watch party while Trump&#8217;s son Donald Trump Jr. has already started pumping his fist in the air.
See Also:&nbsp;<a href="https://www.benzinga.com/news/24/11/41710411/market-analyst-who-predicted-trumps-2016-win-and-bidens-2020-victory-now-sees-former-president-retak?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Market Analyst Who Predicted Trump&#8217;s 2016 Win And Biden&#8217;s 2020 Victory, Now Sees Former President Retaking The White House With &#8216;Large Majority Of Swing States&#8217;</a>
Earlier at Mar-a-Lago on election night, Eduardo Bolsonaro, son of former Brazilian President Jair Bolsonaro, and Nigel Farage, a prominent anti-immigration figure and leader of the U.K.&#8217;s Reform Party were in attendance.
Other notable figures at Mar-a-Lago included billionaire Elon Musk and former Fox News host Tucker Carlson.
On the other hand, the mood at the Harris campaign&#8217;s&nbsp;election night watch party at&nbsp;Howard University has reportedly shifted. The campaign has stopped its CNN broadcasts, and some supporters have begun to depart from the event.
Trump campaign spokesperson, Karoline Leavitt, remarked on the situation at the Harris watch party, saying, &#8220;Sounds&nbsp;like the joy has left&nbsp;the building.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Sounds like the joy has left the building&#8230; <a href="https://t.co/WlWCjkGJrs">pic.twitter.com/WlWCjkGJrs</a>
&mdash; Karoline Leavitt (@kleavittnh) <a href="https://twitter.com/kleavittnh/status/1854029646947348607?ref_src=twsrc%5Etfw">November 6, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
As the night continues, it is reported that Vice President Harris has no plans to address the public, reported Associated Press, citing a person familiar with the White House.
Why It Matters: This development comes after Trump&#8217;s victory in North Carolina, a key swing state in the 2024 presidential race.
Trump secured the <a href="https://www.benzinga.com/news/24/11/41764893/trump-secures-key-swing-state-north-carolina-extending-lead-over-harris-in-2024-presidential-race">state&#8217;s 16 electoral votes</a> with a significant lead over Harris.
Trump also won in Georgia. In fact, Georgia has become the first state to flip from the 2020 election results with Trump's victory.
Four years ago, Trump lost Georgia to Democrat Joe Biden by a slim margin of 11,779 votes—a number that became notable after Trump pressed Georgia election officials to help him find just enough votes to surpass Biden's total.
Image via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/politics/24/11/41732623/bakery-that-often-predicts-election-outcomes-has-this-candidate-winning-in-trump-harris-battle-d?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Bakery That Often Predicts Election Outcomes Has This Candidate Winning In Trump, Harris Battle: &#8216;Doughmacracy For All!&#8217;</a></li>
</ul>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.

Trump Packs In Crowds While Harris Shuts Down CNN: 'The Joy Has Left The Building' — No Plans For VP To Speak Tonight

Yields on U.S. sovereign debt rose during election night as investors digested the preliminary results from the closely contested fight between Donald Trump and Kamala Harris.
What happened: The benchmark 10-year Treasury yield popped 12 basis points to 4.412%, a level not seen since July 2.&nbsp;
Similarly, the yield on 2-year government bonds lifted 6 basis points to 4.262%, the highest since last week of July. The yields on the 30-year Treasury lifted 15 basis points to 4.606% as of this writing.&nbsp;
The uptick comes as the market raised expectations of Trump's White House comeback after the GOP nominee won battleground states of North Carolina and Georgia.&nbsp;
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41756625/will-donald-trump-prematurely-claim-victory-5-polymarket-markets-to-watch-on-election-nigh">Will Donald Trump Prematurely Claim Victory? 5 Polymarket Markets To Watch On Election Night</a>
The market became wary of each candidate's fiscal policies as both Trump and Harris have <a href="https://www.benzinga.com/government/24/10/41611073/trump-vs-harris-how-their-fiscal-plans-could-add-trillions-to-the-us-national-debt">proposed expansive tax and spending measures</a> that would deepen the debt — already projected to reach a historic high in the coming years.
According to the CRFB&#8217;s central estimate, Trump would increase the national debt by $7.75 trillion between 2026 and 2035, leading the government to issue more bonds to fund the deficit.&nbsp;
Aside from Treasury securities, other <a href="https://www.benzinga.com/news/24/11/41763731/bitcoin-past-73k-dollar-gold-stock-futures-rise-as-trump-harris-results-trickle-in">market indices rose sharply</a>, including stock futures, the dollar, and gold, while oil fell. 
Photo by Steve Heap on Shutterstock
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41763299/trump-themed-cryptos-nfts-surge-in-expectations-of-former-presidents-victory-coin-inspired">Trump-Themed Cryptos, NFTs Surge In Expectations Of Former President&#8217;s Victory — Coin Inspired By Harris Falls 13%</a></li>
</ul>

Treasury Yields Pop On Trump Victory Chances, 10-Year Benchmark Reaches 4-Month High

BUSINESS OUTLOOK FOR FULL-YEAR 2024 CONFIRMED } Group revenues expected in the range of € 790 – 820 m (2023: € 781.4 m).&nbsp; &nbsp;R&amp;D expenditures are expected in a range of € 50 – 60 m (2023: € 64.8 m).&nbsp; &nbsp;Adjusted Group EBITDA is expected to reach € 15 – 35 m (2023: € 66.4 m).

Evotec Reaffirms 2024 Outlook: Revenues Of €790M-€820M, And Adjusted Group EBITDA Of €15M-€35M

Evotec (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVO#NASDAQ">EVO</a>) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(0.10) by 21 percent. This is a 0.83 percent decrease over losses of $(0.12) per share from the same period last year. The company reported quarterly sales of $203.213 million which missed the analyst consensus estimate of $208.977 million by 2.76 percent. This is a 4.88 percent decrease over sales of $213.639 million the same period last year.

Evotec Q3 2024 GAAP EPS $(0.12) Misses $(0.10) Estimate, Sales $203.213M Miss $208.977M Estimate

Benzinga Election Update: AP Projects Trump With 247 Electoral Votes, Harris With 210 Electoral Votes; AP Projects Trump To Win Georgia And Nebraska

Editor&#8217;s Note: This article has been updated with the latest developments.
As polls begin to close for the 2024 presidential election, the nation waits to see if Donald Trump or Kamala Harris will secure a historic victory.
Trump has secured Kentucky and Indiana, while Harris has won Vermont, <a href="https://decisiondeskhq.com/results/2024/General/President/">according</a> to the Associated Press. With 34% of votes counted in Kentucky, Trump leads with 64.6%. In Indiana, with 24% of votes counted, Trump holds 64%. Meanwhile, with 20% of Vermont&#8217;s votes tallied, Harris has 69%.
In Kentucky, Trump received the endorsement of Senate GOP Leader Mitch McConnell (R-Ky.) despite their previous differences over the Jan.6 Capitol Riots, noted AP.
Vermont is considered a Democrat stronghold and the state&#8217;s Republican Governor Phil Scott voted Democrat in this election, according to the report.
Trump&#8217;s former Vice President and former Indiana Governor Mike Pence <a href="https://www.benzinga.com/news/24/03/37764902/no-surprise-former-trump-ally-refuses-to-endorse-ex-president-in-2024-cites-differences-in-conservat">did not endorse</a> him in the 2024 run but the Hoosier State is a reliable GOP stronghold where the party has held the governor&#8217;s office for the past two decades.
West Virginia voted for Trump for the third straight presidential election cycle as well. No democrat has won the presidential election in the state since Bill Clinton in 1996, according to AP.
Florida, the third-largest prize of the night in electoral votes, delivered a predictable victory for Trump, as the state has trended Republican over the past decade, noted AP.
The last Democrat to carry Florida was Barack Obama in 2012, but since then, the state has solidified its shift toward the GOP in statewide elections.
The rejection of the abortion rights measure marks Florida as the first state where such a proposal has failed since the overturning of Roe v. Wade in 2022. The initiative sought to prevent lawmakers from imposing abortion restrictions before viability or when necessary to protect the health of the patient.
Trump&#8217;s victory in Georgia marks the state&#8217;s shift from the 2020 election results, becoming the first to flip.
Key Battleground States
As of early morning updates, Trump holds leads in multiple battleground states, with notable margins in some areas:
<ul>
<li>Georgia: Trump leads by 2% with 93% of votes counted.</li>
<li>North Carolina: Trump has a 3% lead with 92% of the vote in.</li>
<li>Florida: Trump holds a substantial 13% lead, with 98% of votes counted.</li>
<li>Maine's 2nd Congressional District: Trump leads by 11% with 45% reporting.</li>
<li>Pennsylvania: Trump leads by 3% with 86% of votes counted.</li>
<li>Arizona: Trump has a narrow lead of less than 1% with 51% of votes tallied.</li>
<li>Michigan: Trump is ahead by 6% with 53% counted.</li>
<li>Wisconsin: Trump leads by 4% with 81% of votes counted.</li>
</ul>
On the Democratic side, Nebraska's 2nd Congressional District shows Harris in the lead by 8% with 84% of votes counted.
"We still have votes to count. We still have states that have not been called yet. We will continue overnight to fight to make sure that every vote is counted," Cedric Richmond, Harris' campaign co-chair, said on Tuesday, according to AP. "So you won't hear from the vice president tonight, but you will hear from her tomorrow."
Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/11/41760961/djt-stock-volatile-on-election-day-donald-trumps-media-company-reports-q3-earnings-growth-initiativ">DJT Stock Volatile On Election Day: Donald Trump&#8217;s Media Company Reports Q3 Earnings, Growth Initiatives</a></li>
</ul>
Image via Wikimedia Commons
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/topic/Kaustubh-Bagalkote" target="_blank" rel="noreferrer noopener">Kaustubh Bagalkote</a>

Global

Trump Wins Georgia, Leading In Key Battleground States Of Michigan, Pennsylvania, Arizona — Harris Campaign Co-Chair Addresses Demoralized Election Watch Party (UPDATED)

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to dive into the biggest pre-market stock movers on Thursday morning with all of the latest news this morning!



Moving stocks on Thursday are loads of earnings reports, a public stock pricing, and exclusive license deal and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Conduit Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/cdt-stock-quote/">CDT</a>) stock is rocketing more than 68% after announcing an <a href="https://www.nasdaq.com/press-release/conduit-pharmaceuticals-enters-exclusive-license-agreement-astrazeneca-multiple">exclusive license agreement</a>.</li>



<li>Anew Medical (NASDAQ:<a href="https://investorplace.com/stock-quotes/wena-stock-quote/">WENA</a>) shares are soaring over 49% alongside heavy pre-market trading.</li>



<li>Harrow (NASDAQ:<a href="https://investorplace.com/stock-quotes/hrow-stock-quote/">HROW</a>) stock is surging more than 39% with its <a href="https://finance.yahoo.com/news/harrow-announces-second-quarter-2024-200100329.html">latest earnings report</a>.</li>



<li>1847 Holdings (NYSEMKT:<a href="https://investorplace.com/stock-quotes/efsh-stock-quote/">EFSH</a>) shares are rising over 30% despite a lack of news this morning.</li>



<li>LuxUrban Hotels (NASDAQ:<a href="https://investorplace.com/stock-quotes/luxh-stock-quote/">LUXH</a>) stock is increasing more than 26% without any clear news today.</li>



<li>Coeptis Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/coep-stock-quote/">COEP</a>) shares are climbing over 24% on Thursday morning.</li>



<li>Aspen Aerogels (NYSE:<a href="https://investorplace.com/stock-quotes/aspn-stock-quote/">ASPN</a>) stock is heading close to 23% higher <a href="https://www.tipranks.com/news/company-announcements/aspen-aerogels-projects-financial-outlook-for-2024-2">with its new guidance</a>.</li>



<li>CompoSecure (NASDAQ:<a href="https://investorplace.com/stock-quotes/cmpo-stock-quote/">CMPO</a>) shares are gaining more than 19% on <a href="https://au.finance.yahoo.com/news/composecure-inc-cmpo-q2-earnings-233506766.html">Q2 earnings and revenue beats</a>.</li>



<li>Digital Turbine (NASDAQ:<a href="https://investorplace.com/stock-quotes/apps-stock-quote/">APPS</a>) stock is jumping over 18% with its <a href="https://www.prnewswire.com/news-releases/digital-turbine-reports-fiscal-2025-first-quarter-financial-results-302217006.html">most recent earnings report</a>.</li>



<li>Klaviyo (NYSE:<a href="https://investorplace.com/stock-quotes/kvyo-stock-quote/">KVYO</a>) shares are up more than 18% <a href="https://www.businesswire.com/news/home/20240807687579/en/Klaviyo-Announces-Second-Quarter-2024-Financial-Results">after a guidance increase</a>.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Cardlytics (NASDAQ:<a href="https://investorplace.com/stock-quotes/cdlx-stock-quote/">CDLX</a>) stock is crashing over 54% with its <a href="https://www.nasdaq.com/press-release/cardlytics-announces-second-quarter-2024-financial-results-2024-08-07">earnings report and a CEO change</a>.</li>



<li>Outset Medical (NASDAQ:<a href="https://investorplace.com/stock-quotes/om-stock-quote/">OM</a>) shares are plummeting more than 47% after <a href="https://finance.yahoo.com/news/outset-medical-inc-om-reports-223509136.html">missing Q2 revenue estimates</a>.</li>



<li>Bumble (NASDAQ:<a href="https://investorplace.com/stock-quotes/bmbl-stock-quote/">BMBL</a>) stock is diving over 40% after <a href="https://www.reuters.com/technology/bumble-dives-revenue-forecast-cut-triggers-worries-over-turnaround-2024-08-08/">cutting its revenue guidance</a>.</li>



<li>Viracta Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/virx-stock-quote/">VIRX</a>) shares are tumbling nearly 39% without any obvious news today.</li>



<li>Greenlane (NASDAQ:<a href="https://investorplace.com/stock-quotes/gnln-stock-quote/">GNLN</a>) stock is taking a more than 36% beating <a href="https://www.nasdaq.com/press-release/greenlanes-vaporcom-named-usa-todays-list-americas-top-online-retail-shops-recent">following a recent rally</a>.</li>



<li>JFrog (NASDAQ:<a href="https://investorplace.com/stock-quotes/frog-stock-quote/">FROG</a>) shares are sliding over 26% on <a href="https://finance.yahoo.com/news/jfrog-nasdaq-frog-misses-q2-202336803.html">missed Q2 estimates</a>.</li>



<li>Dutch Bros (NYSE:<a href="https://investorplace.com/stock-quotes/bros-stock-quote/">BROS</a>) stock is dropping more than 21% <a href="https://seekingalpha.com/news/4136791-coffee-jolt-dutch-bros-gets-crushed-after-just-a-slight-miss-with-revenue-guidance">after missing estimates</a>.</li>



<li>Know Labs (NYSEMKT:<a href="https://investorplace.com/stock-quotes/knw-stock-quote/">KNW</a>) shares are decreasing over 21% after <a href="https://www.nasdaq.com/press-release/know-labs-inc-announces-pricing-3445-million-public-offering-2024-08-07">pricing a public offering</a>.</li>



<li>Vertex Energy (NASDAQ:<a href="https://investorplace.com/stock-quotes/vtnr-stock-quote/">VTNR</a>) stock is falling more than 20% <a href="https://www.stocktitan.net/news/VTNR/vertex-energy-announces-second-quarter-2024-enonsrelirjb.html">with its Q2 earnings report</a>,</li>



<li>Fastly (NYSE:<a href="https://investorplace.com/stock-quotes/fsly-stock-quote/">FSLY</a>) shares close out our pre-market stock movers down over 19% <a href="https://www.investing.com/news/stock-market-news/fastly-shares-plunge-19-as-guidance-disappoints-despite-solid-q2-93CH-3560546">on a lackluster guidance</a>.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/08/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-thursday-aug-8th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Outset Medical&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/om-stock-quote/">OM</a>) stock is taking a beating on Thursday after the medical technology company announced earnings results for the <a href="https://finance.yahoo.com/news/outset-medical-reports-second-quarter-200300800.html">second quarter of the year</a>.



The Outset Medical earnings report starts with an adjusted EPS of -47 cents. That&rsquo;s worse than the <a href="https://finance.yahoo.com/news/outset-medical-inc-om-reports-223509136.html">-43 cents per share</a> that Wall Street was expecting. That&rsquo;s despite it being better than the -69 cents per share from the same period of the year prior.



On top of that, Outset Medical posted revenue of $27.39 million during the quarter. That&rsquo;s another miss compared to analysts&rsquo; estimate of $31.37 million for the period. It&rsquo;s also a drop year-over-year from $36.04 million.



Leslie Trigg, chairman and CEO of Outset Medical, said the following about the earnings results.




&ldquo;During the quarter, the number of treatments performed each month on Tablo continued at record levels, as utilization remained high and gross margin materially expanded as it has each quarter for more than 3 years. At the same time, new console placements were below our expectations and will be lower than we originally forecasted for the year.&rdquo;




<h2>What&rsquo;s Next for OM Stock</h2>



Things aren&rsquo;t looking good for Outset Medical after it cut its guidance for 2024. It now expects its revenue for the year to come in at approximately $110 million. Prior to that, it was expecting revenue of $145 million to $153 million. It&rsquo;s also worth mentioning that Wall Street&rsquo;s estimate for the year is $146.41 million in revenue.



OM stock is down 33.5% as of Thursday morning.



Investors will want to keep reading for more of the most recent stock market news!



We have all of the hottest stock market stories ready to go on Thursday! That includes what&rsquo;s going on with shares of Cardlytics&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/cdlx-stock-quote/">CDLX</a>) stock, Anew Medical&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/wena-stock-quote/">WENA</a>) stock and Conduit Pharmaceuticals&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/cdt-stock-quote/">CDT</a>) stock today. You can catch up on all of this at the links below!



<h2>More Stock Market News for Thursday</h2>



<ul><li><a href="https://investorplace.com/2024/08/why-is-cardlytics-cdlx-stock-down-57-today/">Why Is Cardlytics (CDLX) Stock Down 57% Today?</a></li>



<li><a href="https://investorplace.com/2024/08/why-is-anew-medical-wena-stock-up-37-today/">Why Is Anew Medical (WENA) Stock Up 37% Today?</a></li>



<li><a href="https://investorplace.com/2024/08/why-is-conduit-pharmaceuticals-cdt-stock-up-123-today/">Why Is Conduit Pharmaceuticals (CDT) Stock Up 123% Today?</a></li>
</ul>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/08/why-is-outset-medical-om-stock-down-34-today/">Why Is Outset Medical (OM) Stock Down 34% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Outset Medical (OM) Stock Down 34% Today?

Outset Medical plunges after Q2 miss; RBC downgrades

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Outset Medical (OM – Research Report), Certara (CERT – Research R...

Analysts Offer Insights on Healthcare Companies: Outset Medical (OM), Certara (CERT) and Harrow Health (HROW)

Outset Medical (OM) has shared an update. Jim Hinrichs resigned from his positions on the Board and as Audit Committee Chair of Outset Medical, Inc...

Outset Medical Announces Board and Committee Leadership Changes

THE LAWSUIT: A class action securities lawsuit was filed against Outset Medical, Inc. (OM) that seeks to recover losses of Outset Medical sharehold...

Class Action Filed Against Outset Medical, Inc. (OM) Seeking Recovery for Investors – Contact Levi & Korsinsky LLP

In a report released on October 8, Shagun Singh Chadha from RBC Capital maintained a Hold rating on Outset Medical (OM – Research Report), with a p...

RBC Capital Remains a Hold on Outset Medical (OM)

Warning: OM is at high risk of performing badly

A class action lawsuit was filed against Outset Medical ($OM) by Levi & Korsinsky on August 29, 2024. The plaintiffs (shareholders) alleged that th...

Class Action Lawsuit Against Outset Medical (NASDAQ:OM)

Medical Technology and Digital Health Analyst Thibault holds a virtual meeting with CEO Trigg and CFO Ahmed on November 12 hosted by BTIG. Publishe...

Outset Medical management to meet virtually with BTIG

APPS

ASPN

BMBL

BROS

CDLX

CERT

CMPO

COEP

EFSH

FROG

FSLY

GNLN

HROW

KVYO

LUXH

VIRX

VTNR

WENA

Legal

Press Releases

OM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Outset Medical, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Analyst Ratings

New Research Highlights Improvements in Quality of Life and Caregiver Experience for Home Hemodialysis Patients Using Tablo

Outset Medical, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. Oct. 28, 2024 Deadline to file Lead Plaintiff Motion

SHAREHOLDER ALERT: Holzer & Holzer, LLC Reminds Investors of the October 28, 2024 Lead Plaintiff Deadline in Class Action Lawsuits Filed on Behalf of Verve Therapeutics, Inc. (VERV), Sage Therapeutics, Inc. (SAGE), and Outset Medical, Inc. (OM) Shareholders

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Outset Medical, Inc. (OM)

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Outset Medical, Inc. - OM

Penny Stocks

OM Investors Have Opportunity to Lead Outset Medical, Inc. Securities Fraud Lawsuit

OM DEADLINE: ROSEN, A RANKED AND LEADING FIRM, Encourages Outset Medical, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important October 28 Deadline in Securities Class Action – OM

Outset Medical, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before October 28, 2024 to Discuss Your Rights - OM

Comments

Outset Medical

Outset Medical (OM) Opzioni

Outset Medical (NASDAQ:OM) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO